期刊文献+

三维适形放疗治疗残胃再发癌近期疗效观察 被引量:1

Effect of three-dimensional conformal radiation on cancer of gastric remnant
下载PDF
导出
摘要 目的:回顾性分析三维适形放射治疗残胃再发癌的近期疗效。方法:采用多叶光栅技术,10MV-X线,5-7个共面或非共面固定射野。90%等剂量曲线包绕靶区并以该等剂量线作为处方剂量,边缘剂量200cGy,每日治疗1次,每周治疗5次,剂量4000cGy复查CT,根据CT适当调整照射靶区和照射剂量。总剂量6000cGy或以上。结果:治疗后3个月、6个月复查CR分别为2/10、3/10,PR为6/10、5/10。随访9-48个月,最短存活8个月,1年生存50%,2年生存10%,3年生存10%。结论:三维适形放射治疗通过对治疗计划的优化,对不能接受根治切除手术的病人的治疗是必要的、有效的。 Objective:To observe the short - term curative effects of radiotherapy on cancer of gastric remnant. Methods: The predominant method of treatment was a 5 - 7field technique by 10my - X line, leaflness grating. The daily radiation doses were 2 Gy for 5 days a week . The total doses was sixty GY or more. Results: Two and 3 of 10 patients achieved an initial CR after treatment 3 months and 6 months respectively ,6 and 5 of 10 patients achieved an initial PR after treatment 3 months and 6 months respectively,one -year suavival rate was 50% ,two -year suavival rate was 10%, three - year suavival rate was 10%. Conclusion: For patients with cancer of gastric remnant 3DCRT is a high effective method.
作者 张继红
出处 《现代肿瘤医学》 CAS 2008年第8期1353-1354,共2页 Journal of Modern Oncology
关键词 残胃再发癌 放射治疗 三维适形放射治疗 cancer of gastric remnant radiation therapy three -dimensional conformal radiation therapy (3DCRT)
  • 相关文献

参考文献3

二级参考文献14

共引文献39

同被引文献12

  • 1Macdonald JS,Smalley SR,Benedetti J. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction[J].New England Journal of Medicine,2001,(10):725-730.
  • 2Jemal A,Siegel R,Ward E. Cancer statistics[J].CA:A Cancer Journal for Clinicians,2006.106.
  • 3Roukos DH,Kappas AM. Perspectives in the treatment of gastric cancer(review)[J].Oncology,2005,(02):98-107.
  • 4Kozak KR,Moody JS. The survival impact of the intergroup 0116 trial on patients with gastric cancer[J].International Journal of Radiation Oncology,Biology,Physics,2008,(02):517-521.
  • 5Coburn NG,Guller U,Baxter NN. Adjuvant therapy for resected gastric cancer-rapid,yet incomplete adoption following results of intergroup 0116 trial[J].International Journal of Radiation Oncology,Biology,Physics,2008,(04):1073-1080.
  • 6Hartgrink HH,van de Velde CJ. Status of extended lymph node dissection:locoregional control is the only way to survive gastric cancer[J].Journal of Surgical Oncology,2005,(03):153-165.
  • 7Lim DH,Kim DY,Kang MK. Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradioterapy.A radiation oncologist's view[J].British Journal of Cancer,2004,(01):11-17.
  • 8Kim S,Lim DH,Lee J. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach[J].International Journal of Radiation Oncology,Biology,Physics,2005,(05):1279-1285.
  • 9Fiorica F,Cartei F,Enea M. The impact of radiotherapy on survival in respectable gastric carcinoma:A meta analysis of literature data[J].Cancer Treatment Reviews,2007,(08):729-740.
  • 10Jansen EP,Saunders MP,Boot H. Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer[J].International Journal of Radiation Oncology,Biology,Physics,2007,(03):781-785.

引证文献1

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部